![COVID | Free Full-Text | Subjective Reasons for COVID-19 Vaccine Hesitancy and Sociodemographic Predictors of Vaccination in Nigeria: An Online Survey COVID | Free Full-Text | Subjective Reasons for COVID-19 Vaccine Hesitancy and Sociodemographic Predictors of Vaccination in Nigeria: An Online Survey](https://pub.mdpi-res.com/covid/covid-02-00097/article_deploy/html/images/covid-02-00097-g001.png?1665191411)
COVID | Free Full-Text | Subjective Reasons for COVID-19 Vaccine Hesitancy and Sociodemographic Predictors of Vaccination in Nigeria: An Online Survey
![COVID-19 Vaccination Storage and Supply Chain Strategies : February 2021 - Pharmacy Purchasing & Products Magazine COVID-19 Vaccination Storage and Supply Chain Strategies : February 2021 - Pharmacy Purchasing & Products Magazine](http://www.pppmag.com/rimage/600/600/files/article-images/ppp_2102_VaccineStorage_CS_Table1.jpg)
COVID-19 Vaccination Storage and Supply Chain Strategies : February 2021 - Pharmacy Purchasing & Products Magazine
![Pfizer, BioNTech nab COVID-19 vaccine authorization from U.K. for first-ever marketed mRNA shot | Fierce Pharma Pfizer, BioNTech nab COVID-19 vaccine authorization from U.K. for first-ever marketed mRNA shot | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1606901673/GettyImages-1218961180.jpg/GettyImages-1218961180.jpg?VersionId=b8Sq12oXKiSJPRJvCCuBVKcEbEMs5wpg)
Pfizer, BioNTech nab COVID-19 vaccine authorization from U.K. for first-ever marketed mRNA shot | Fierce Pharma
![Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7102e1_PfizerMIS-C_IMAGE_07Jan22_SOCIAL_1200x675.jpg?_=63592)